ATM and p53 are essential in the cell-cycle containment of DNA breaks during V(D)J recombination in vivo

Oncogene

Volumn 29, Issue 7, 2010, Pages 957-965

  Dujka, M E ^a   Puebla Osorio, N ^a   Tavana, O ^a   Sang, M ^a   Zhu, C ^a  

^a UNIVERSITY OF TEXAS   (United States)

Author keywords

ATM; Cell cycle control; Genomic instability; V(D)J recombination

Indexed keywords

ATM PROTEIN; HISTONE H2AX; PROTEIN P53; RAG2 PROTEIN; RECOMBINASE;

ANIMAL CELL; ARTICLE; CELL CYCLE REGULATION; CONTROLLED STUDY; DOUBLE STRANDED DNA BREAK; GENE LOCUS; GENETIC RECOMBINATION; GENOMIC INSTABILITY; IN VIVO STUDY; LYMPHOCYTE; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN FUNCTION; PROTEIN PHOSPHORYLATION; SIGNAL TRANSDUCTION; THYMOCYTE;

ANIMALS; CELL CYCLE; CELL CYCLE PROTEINS; DNA BREAKS, DOUBLE-STRANDED; DNA-BINDING PROTEINS; GENE REARRANGEMENT, T-LYMPHOCYTE; GENETIC LOCI; GENOMIC INSTABILITY; HISTONES; HOMEODOMAIN PROTEINS; HUMANS; LYMPHOCYTES; MICE; PHOSPHORYLATION; PROTEIN-SERINE-THREONINE KINASES; RECEPTORS, ANTIGEN, T-CELL, ALPHA-BETA; RECOMBINATION, GENETIC; SIGNAL TRANSDUCTION; TUMOR SUPPRESSOR PROTEIN P53; TUMOR SUPPRESSOR PROTEINS; VDJ EXONS;

ATAXIA TELANGIECTASIA;

EID: 77149162027     PISSN: 09509232     EISSN: 14765594     Source Type: Journal    
DOI: 10.1038/onc.2009.394     Document Type: Article

References (42)

1. Bakkenist CJ, Kastan MB. (2003). DNA damage activates ATM through intermolecular autophosphorylation and dimer dissociation. Nature 421: 499-506.
2. Barlow C, Hirotsune S, Paylor R, Liyanage M, Eckhaus M, Collins F et al. (1996). Atm-deficient mice: a paradigm of ataxia telangiecta-sia. Cell 86: 159-171.
3. Bassing CH, Chua KF, Sekiguchi J, Suh H, Whitlow SR, Fleming JC et al. (2002). Increased ionizing radiation sensitivity and genomic instability in the absence of histone H2AX. Proc Natl Acad Sci USA 99: 8173-8178.
4. Bassing CH, Ranganath S, Murphy M, Savic V, Gleason M, Alt FW. (2008). Aberrant V(D)J recombination is not required for rapid development of H2ax/p53-deficient thymic lymphomas with clonal translocations. Blood 111: 2163-2169.
5. Bassing CH, Suh H, Ferguson DO, Chua KF, Manis J, Eckersdorff M et al. (2003). Histone H2AX: a dosage-dependent suppressor of oncogenic translocations and tumors. Cell 114: 359-370.
6. Borghesani PR, Alt FW, Bottaro A, Davidson L, Aksoy S, Rathbun GA et al. (2000). Abnormal development of Purkinje cells and lymphocytes in Atm mutant mice. Proc Natl Acad Sci USA 97: 3336-3341.
7. Bredemeyer AL, Huang CY, Walker LM, Bassing CH, Sleckman BP. (2008). Aberrant V(D)J recombination in ataxia telangiectasia mutated-deficient lymphocytes is dependent on nonhomologous DNA end joining. J Immunol 181: 2620-2625.
8. Bredemeyer AL, Sharma GG, Huang CY, Helmink BA, Walker LM, Khor KC et al. (2006). ATM stabilizes DNA double-strand-break complexes during V(D)J recombination. Nature 442: 466-470.
9. Callen E, Jankovic M, Difilippantonio S, Daniel JA, Chen HT, Celeste A et al. (2007). ATM prevents the persistence and propagation of chromosome breaks in lymphocytes. Cell 130: 63-75.
10. Celeste A, Petersen S, Romanienko PJ, Fernandez-Capetillo O, Chen HT, Sedelnikova OA et al. (2002). Genomic instability in mice lacking histone H2AX. Science 296: 922-927.
11. Chen HT, Bhandoola A, Difilippantonio MJ, Zhu J, Brown MJ, Tai X et al. (2000). Response to RAG-mediated VDJ cleavage by NBS1 and gamma-H2AX. Science 290: 1962-1965.
12. Desiderio S, Lin WC, Li Z. (1996). The cell cycle and V(D)J recombination. Curr Top Microbiol Immunol 217: 45-59.
13. Donehower LA, Harvey M, Slagle BL, McArthur MJ, Montgomery Jr CA, Butel JS et al. (1992). Mice deficient for p53 are developmen-tally normal but susceptible to spontaneous tumours. Nature 356: 215-221.
14. Franco S, Gostissa M, Zha S, Lombard DB, Murphy MM, Zarrin AA et al. (2006). H2AX prevents DNA breaks from progressing to chromosome breaks and translocations. Mol Cell 21: 201-214.
15. Gao Y, Chaudhuri J, Zhu C, Davidson L, Weaver DT, Alt FW. (1998). A targeted DNA-PKcs-null mutation reveals DNA-PK-independent functions for KU in V(D)J recombination. Immunity 9: 367-376.
16. Guidos CJ, Williams CJ, Grandal I, Knowles G, Huang MT, Danska JS. (1996). V(D)J recombination activates a p53-dependent DNA damage checkpoint in scid lymphocyte precursors. Genes Dev 10: 2038-2054.
17. Huang CY, Sharma GG, Walker LM, Bassing CH, Pandita TK, Sleckman BP. (2007). Defects in coding joint formation in vivo in developing ATM-deficient B and T lymphocytes. J Exp Med 204: 1371-1381.
18. Jankovic M, Nussenzweig A, Nussenzweig MC. (2007). Antigen receptor diversification and chromosome translocations. Nat Immunol 8: 801-808.
19. Jiang H, Chang FC, Ross AE, Lee J, Nakayama K, Desiderio S. (2005). Ubiquitylation of RAG-2 by Skp2-SCF links destruction of the V(D)J recombinase to the cell cycle. Mol Cell 18: 699-709.
20. Lavin MF. (2008). Ataxia-telangiectasia: from a rare disorder to a paradigm for cell signalling and cancer. Nat Rev Mol Cell Biol 9: 759-769.
21. Lee GS, Neiditch MB, Salus SS, Roth DB. (2004). RAG proteins shepherd double-strand breaks to a specific pathway, suppressing error-prone repair, but RAG nicking initiates homologous recombination. Cell 117: 171-184.
22. Lee JH, Paull TT. (2005). ATM activation by DNA double-strand breaks through the Mre11-Rad50-Nbs1 complex. Science 308: 551-554.
23. Liao MJ, Zhang XX, Hill R, Gao J, Qumsiyeh MB, Nichols W et al. (1998). No requirement for V(D)J recombination in p53-deficient thymic lymphoma. Mol Cell Biol 18: 3495-3501.
24. Livak KJ, Schmittgen TD. (2001). Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) Method. Methods 25: 402-408.
25. Liyanage M, Weaver Z, Barlow C, Coleman A, Pankratz DG, Anderson S et al. (2000). Abnormal rearrangement within the alpha/delta T-cell receptor locus in lymphomas from Atm-deficient mice. Blood 96: 1940-1946.
26. McBlane JF, van Gent DC, Ramsden DA, Romeo C, Cuomo CA, Gellert M et al. (1995). Cleavage at a V(D)J recombination signal requires only RAG1 and RAG2 proteins and occurs in two steps. Cell 83: 387-395.
27. Monroe RJ, Seidl KJ, Gaertner F, Han S, Chen F, Sekiguchi J et al. (1999). RAG2:GFP knockin mice reveal novel aspects of RAG2 expression in primary and peripheral lymphoid tissues. Immunity 11: 201-212.
28. Oettinger MA, Schatz DG, Gorka C, Baltimore D. (1990). RAG-1 and RAG-2, adjacent genes that synergistically activate V(D)J recombination. Science 248: 1517-1523.
29. Perkins EJ, Nair A, Cowley DO, Van Dyke T, Chang Y, Ramsden DA. (2002). Sensing of intermediates in V(D)J recombination by ATM. Genes Dev 16: 159-164.
30. Robbiani DF, Bothmer A, Callen E, Reina-San-Martin B, Dorsett Y, Difilippantonio S et al. (2008). AID is required for the chromosomal breaks in c-myc that lead to c-myc/IgH translocations. Cell 135: 1028-1038.
31. Rogakou EP, Pilch DR, Orr AH, Ivanova VS, Bonner WM. (1998). DNA double-stranded breaks induce histone H2AX phosphorylation on serine 139. J Biol Chem 273: 5858-5868.
32. Savic V, Yin B, Maas NL, Bredemeyer AL, Carpenter AC, Helmink BA et al. (2009). Formation of dynamic gamma-H2AX domains along broken DNA strands is distinctly regulated by ATM and MDC1 and dependent upon H2AX densities in chromatin. Mol Cell 34: 298-310.
33. Schatz DG, Oettinger MA, Baltimore D. (1989). The V(D)J recombination activating gene, RAG-1. Cell 59: 1035-1048.
34. Schlissel M, Constantinescu A, Morrow T, Baxter M, Peng A. (1993). Double-strand signal sequence breaks in V(D)J recombination are blunt, 5'-phosphorylated, RAG-dependent, and cell cycle regulated. Genes Dev 7: 2520-2532.
35. Spilianakis CG, Lalioti MD, Town T, Lee GR, Flavell RA. (2005). Interchromosomal associations between alternatively expressed loci. Nature 435: 637-645.
36. Stiff T, O'Driscoll M, Rief N, Iwabuchi K, Lobrich M, Jeggo PA. (2004). ATM and DNA-PK function redundantly to phosphorylate H2AX after exposure to ionizing radiation. Cancer Res 64: 2390-2396.
37. Tsai AG, Lu H, Raghavan SC, Muschen M, Hsieh CL, Lieber MR. (2008). Human chromosomal translocations at CpG sites and a theoretical basis for their lineage and stage specificity. Cell 135: 1130-1142.
38. Vacchio MS, Olaru A, Livak F, Hodes RJ. (2007). ATM deficiency impairs thymocyte maturation because of defective resolution of T cell receptor alpha locus coding end breaks. Proc Natl Acad Sci USA 104: 6323-6328.
39. 2 and mitosis by cyclin B1 flow cytometry. Cytometry 27: 250-254.
40. Winrow CJ, Pankratz DG, Vibat CR, Bowen TJ, Callahan MA, Warren AJ et al. (2005). Aberrant recombination involving the granzyme locus occurs in Atm-/-T-cell lymphomas. Hum Mol Genet 14: 2671-2684.
41. Yan M, Zhu C, Liu N, Jiang Y, Scofield VL, Riggs PK et al. (2006). ATM controls c-Myc and DNA synthesis during postnatal thymocyte development through regulation of redox state. Free Radic Biol Med 41: 640-648.
42. Zhu C, Roth DB. (1995). Characterization of coding ends in thymocytes of scid mice: implications for the mechanism of V(D)J recombination. Immunity 2: 101-112.